Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Intralesional Vitamin D3 vs Triamcinolone in Alopecia Areata
NCT04660786Phase 2Unknown
- Sponsor
- Alexandria University
- Start
- Nov 2021
- Primary completion
- Dec 2022
- Modality
- Orthosteric Ligands, Metabolically Activated Prodrugs
- Countries
- 1
01
Overview
Phase 2, randomised, single-blind trial of vitamin d in alopecia areata (2 arms), sponsored by Alexandria University. Primary endpoint: Regrowth Score at 3 months. Status: unknown.
02
Drugs
vitamin d
03
Conditions
alopecia areata
Beyond the preview
Go deeper on NCT04660786.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04660786.